Introduction Maintenance therapy is a new treatment paradigm for advanced non–small-cell
lung cancer (NSCLC). We conducted a meta-analysis to evaluate its clinical efficacy in …

Objectives Although maintenance therapy has been a routine treatment paradigm for
advanced non-small cell lung cancer (NSCLC), there is currently lack of direct evidence to …

Purpose The aim was to investigate whether maintenance therapy (MT) is sufficient or not to
improve overall survival (OS) and progress-free survival (PFS) of advanced non-small cell …

A meta-analysis of all relevant randomized controlled trials (RCTs) was performed to assess
the role of maintenance therapy with either a continuation or a switch strategy in the …

Background Maintenance therapy for patients with non-small cell lung cancer (NSCLC) has
gained extensive interest. Varying results for this treatment underpin the need for a synthesis …

With standard doublet chemotherapy for patients with advanced non-small-cell lung cancer
(NSCLC), we have reached an outcome plateau of about 10 months median overall survival …

BACKGROUND: Maintenance therapy is a new treatment paradigm for advanced non-small
cell lung cancer (NSCLC). We conducted a meta-analysis of randomized studies with single …

Introduction Non–small cell lung cancer (NSCLC) is often diagnosed at later stages when
treatment options are limited. Maintenance therapy may prolong the time to disease …

Non-small cell lung cancer (NSCLC) is the leading cause of cancer death in the
industrialized world. Despite significant progress in early stage disease, survival rates for …

Completed trials evaluating consolidation or maintenance therapy or both in patients with
advanced NSCLC consistently demonstrate that this strategy will improve progression free …